It looks like you are visiting from outside of the United States.

Redirecting you to your regional XOMD site in:

5

Oxytocin and Women’s Health in Midlife

Published in Journal of Endocrinology • July 01, 2024

Written by: Galit Levi Dunietz • Lucas J. Tittle • Sunni L. Mumford • Louise M. O’Brien • Ana Baylin • Enrique F. Schisterman • Ronald D. Chervin • Larry J. Young

Download View Original

Abstract

Menopause marks the cessation of fertility and the transition to post-reproductive years. Nearly 1M US women experience menopause annually, but despite the significant impact it has on their physical and mental health, menopause has been insufficiently studied. Oxytocin is a neurohormone that regulates emotionality, social behaviors, and fundamental physiological systems. Localization of oxytocin receptors in the brain, reproductive tissues, bone, and heart support their role in mental health and potentially sleep, along with reproductive and cardiovascular functions. While experimental data linking oxytocin to behavior and physiology in animals are largely consistent, human data are correlative and inconclusive. As women transition into menopause, oxytocin levels decrease while their susceptibility to mood disorders, poor sleep, osteoporosis, and cardiovascular diseases increases. These concurrent changes highlight oxytocin as a potential influence on the health and mood of women along their reproductive lifespan. The review summarizes experimental rodent and non-human primate studies that link oxytocin to reproductive aging and metabolic health and highlights inconclusive findings in studies of women.